Search results for "TYPE 2 DIABETES"

showing 10 items of 659 documents

A matter of fat: insulin resistance and oxidative stress

2012

Background Obesity is linked to insulin resistance (IR), which can lead to type 2 diabetes mellitus. Oxidative stress present in early obesity may favor the progression to comorbid conditions. Objective To examine the relationship between oxidative stress biomarkers and the severity of IR in a group of obese children. Methods Forty obese children with a body mass index (BMI) Z-score ≥ 2 were divided into two groups using the median obtained for the homeostasis model assessment of IR (HOMA-IR). Anthropometric parameters (including body fat composition by bioelectrical impedance) and biochemical parameters were assessed. The following biomarkers of oxidative stress were measured: malondialdeh…

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismType 2 Diabetes Mellitusmedicine.diseaseMalondialdehydemedicine.disease_causeObesityBody fat percentagechemistry.chemical_compoundEndocrinologyInsulin resistancechemistryInternal medicinePediatrics Perinatology and Child HealthInternal MedicinemedicinebusinessBody mass indexBioelectrical impedance analysisOxidative stressPediatric Diabetes
researchProduct

Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes

2010

Diabet. Med. 27, 872–878 (2010) Abstract Aims  Subjects who are at increased risk of developing diabetes may have increased glycaemic variability associated with endothelial dysfunction and possibly subclinical atherosclerosis, which may lead to increased cardiovascular risk observed at the time of diabetes diagnosis. To investigate this hypothesis, we measured endothelial function, carotid intima-media thickness and glycaemic variability using 48-h continuous subcutaneous glucose monitoring in 3 groups of overweight or obese subjects – those without the metabolic syndrome, and those with the metabolic syndrome with or without newly diagnosed Type 2 diabetes. Methods  Consecutive subjects, …

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismType 2 diabetesOverweightmedicine.diseaseEndocrinologyEndocrinologyIntima-media thicknessInternal medicinemedicine.arteryDiabetes mellitusInternal MedicineCardiologymedicineEndothelial dysfunctionmedicine.symptomBrachial arteryMetabolic syndromebusinessBody mass indexDiabetic Medicine
researchProduct

Real-Time Breath Analysis in Type 2 Diabetes Patients During Cognitive Effort

2013

The understanding the functional expression of exhaled volatile organic compounds (VOCs) has gradually expanded from the initial identification of breath pathological markers to direct expression of physiological activity. In the present study we investigated the potential application of breath analysis in real-time monitoring of type 2 diabetes mellitus (T2DM) patients versus control subjects while performing a cognitive task. T2DM is associated with cognitive impairment and neural deficits, because of insulin resistance and high expression of insulin receptors in the hippocampus. We set out to seek the evidence for mutual associations among breath exhale, on the one side, and T2DM and cog…

medicine.medical_specialtybusiness.industryExhalationType 2 Diabetes MellitusCognitionCognitive effortType 2 diabetesmedicine.diseaseBioinformaticsInsulin resistancePhysical medicine and rehabilitationBreath gas analysisDiabetes mellitusMedicinebusiness
researchProduct

COMPARATIVE EFFECTS OF ROSIGLITAZONE AND PIOGLITAZONE ON FASTING AND POSTPRANDIAL LDL-SIZE AND SUBCLASSES IN PATIENTS WITH TYPE-2 DIABETES

2008

medicine.medical_specialtybusiness.industryGeneral MedicineType 2 diabetesmedicine.diseaseFasting glucosePostprandialEndocrinologyInternal medicineInternal Medicinerosiglitazone pioglitazone fasting glucose postprandial glucose LDL type-2 diabetesMedicineIn patientCardiology and Cardiovascular MedicinebusinessRosiglitazonePioglitazonemedicine.drugAtherosclerosis Supplements
researchProduct

FTO and INSIG2 Genotyping Combined with Metabolic and Anthropometric Phenotyping of Morbidly Obese Patients

2013

Obesity is a major health problem worldwide. Associations of obesity with common variants of the fat mass- and obesity-associated gene <i>(FTO) </i>and insulin-induced gene 2 <i>(INSIG2)</i> have been reported in various studies. We aimed to further investigate the association of 2 single nucleotide polymorphisms (SNPs), rs9939609 in <i>FTO</i> and rs7566605 in <i>INSIG2</i>, with body mass index (BMI) and other anthropometric and metabolic parameters in subjects with morbid obesity (BMI ≥40). SNPs rs9939609 and rs7566605 were genotyped in 124 unrelated morbidly obese patients (mean BMI = 50, range 40.1-77.1) from Mainz, Germany, and in 253 no…

medicine.medical_specialtybusiness.industryINSIG2nutritional and metabolic diseasesSingle-nucleotide polymorphismOdds ratioType 2 diabetesmedicine.diseaseObesityImpaired glucose toleranceEndocrinologyInternal medicineGenotypeGeneticsmedicineOriginal ArticlebusinessBody mass indexGenetics (clinical)Molecular Syndromology
researchProduct

Platelet micro-RNA expression in type 2 diabetes mellitus

2013

medicine.medical_specialtybusiness.industryInflammatory responseType 2 Diabetes Mellitusmedicine.diseaseMICROBIOLOGY PROCEDURESEndocrinologyInternal medicinePlatelet-rich plasmaDiabetes mellitusmicroRNAImmunologymedicinePlateletCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient…

2012

Summary Aims:  The choice of insulin at initiation in type 2 diabetes remains controversial. The aim of this study was to assess the occurrence of self-reported severe hypoglycaemia associated with premixed insulin analogues in routine clinical care. Methods:  A 12-month, prospective, observational, multicentre study in patients starting a commonly prescribed premixed insulin analogue (either insulin lispro 25/75 or biphasic insulin aspart 30/70, twice daily) after suboptimal glycaemic control on oral antidiabetic agents. Treatment decisions were made solely in the course of usual practice. Results:  Study follow-up was completed by 991 (85.5%) of the 1150 patients enrolled. At baseline, me…

medicine.medical_specialtybusiness.industryInsulinmedicine.medical_treatmentIncidence (epidemiology)Type 2 Diabetes MellitusGeneral MedicineType 2 diabetesmedicine.diseaseSurgeryDiabetes mellitusInternal medicinemedicineInsulin lisproProspective cohort studybusinessBody mass indexmedicine.drugInternational Journal of Clinical Practice
researchProduct

We-P13:336 Haemostatic and fibrinolytic abnormalities in obese patients and in patients with type 2 diabetes with metabolic syndrome

2006

medicine.medical_specialtybusiness.industryInternal medicineInternal MedicineMedicineIn patientGeneral MedicineType 2 diabetesMetabolic syndromeCardiology and Cardiovascular Medicinebusinessmedicine.diseaseGastroenterologyAtherosclerosis Supplements
researchProduct

Exercise in type 2 diabetes: The mechanisms of resistance and endurance training

2012

This highlight article focuses on the effects of different types of exercise on the prevention and treatment of type 2 diabetes and on future challenges in developing effective preventive strategies. 1.Current prevalence of diabetes in China Cardiovascular diseases have become the leading cause of death in China.Diabetes is a major risk factor for cardiovascular diseases and the rapid change in lifestyle is the main reason for the increased risk for cardiovascular diseases in China.The China

medicine.medical_specialtybusiness.industryPhysical Therapy Sports Therapy and RehabilitationResistance (psychoanalysis)Type 2 diabetesmedicine.diseaseIncreased riskEndurance trainingDiabetes mellitusmedicinePhysical therapyOrthopedics and Sports MedicineRisk factorbusinessIntensive care medicineCause of deathJournal of Sport and Health Science
researchProduct

Diabetes and Dementia

2015

Persons with type 2 diabetes mellitus (DM2) have an increased incidence of cognitive decline and dementia. An increased cortical and subcortical atrophy has been found after controlling for vascular disease and inadequate cerebral circulation. A possible role of insulin resistance and hyperinsulinemia has been suggested to mediate the link between DM2 and Alzheimer’s Disease (AD). Altered insulin signaling may contribute to AD biochemical and histopathological lesions. Both hyperglycemia and hypoglycemia may contribute to cognitive decline in DM2. Recurrent symptomatic and asymptomatic hypoglycemic episodes have been suggested to cause subclinical brain damage, and permanent cognitive impai…

medicine.medical_specialtybusiness.industryPhysiologyType 2 Diabetes MellitusHypoglycemiamedicine.diseaseAsymptomaticEndocrinologyInsulin resistanceInternal medicineDiabetes mellitusmedicineHyperinsulinemiaDementiamedicine.symptomCognitive declinebusinessInternational Journal of Diabetes and Clinical Research
researchProduct